HYLENEX Recombinant
Active substance: hyaluronidase (human recombinant)
INJECTION, SOLUTION · HYALURONIDASE (HUMAN RECOMBINANT) 150 [USP'U]/mL
United StatesActive
Marketing holder: Antares Pharma, Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- HYALURONIDASE (HUMAN RECOMBINANT) · 150 [USP'U]/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208f-9417-737b-bec2-4f941d0ce65e,01a1209b-218c-7cf1-a072-f9449bb3795a;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 18657-117
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- SUBCUTANEOUS
Sources
- product · openFDA NDC · 18657-117 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 18657-117 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 18657-117 · Verified 2026-10-09 · open in source